[go: up one dir, main page]

PE20000548A1 - Derivados de diaza-espiro[3.5]nonano - Google Patents

Derivados de diaza-espiro[3.5]nonano

Info

Publication number
PE20000548A1
PE20000548A1 PE1999000487A PE00048799A PE20000548A1 PE 20000548 A1 PE20000548 A1 PE 20000548A1 PE 1999000487 A PE1999000487 A PE 1999000487A PE 00048799 A PE00048799 A PE 00048799A PE 20000548 A1 PE20000548 A1 PE 20000548A1
Authority
PE
Peru
Prior art keywords
ilo
diaza
alkyl
phenyl
espiro
Prior art date
Application number
PE1999000487A
Other languages
English (en)
Inventor
Andrea Cesura
Jurgen Wichmann
Geo Adam
Sabine Kolczewski
Francois Jenck
Stephan Rover
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of PE20000548A1 publication Critical patent/PE20000548A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/10Spiro-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/08Antiepileptics; Anticonvulsants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/22Anxiolytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/30Drugs for disorders of the nervous system for treating abuse or dependence
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/04Anorexiants; Antiobesity agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Addiction (AREA)
  • Hospice & Palliative Care (AREA)
  • Cardiology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Hydrogenated Pyridines (AREA)

Abstract

SE REFIERE A DERIVADOS DE DIAZA-ESPIRO[3.5]NONANO DE FORMULA I, DONDE R1 ES CICLOALQUILO C6-C12, INDAN-1-ILO, ACENAFTEN-1-ILO, BICICLO[3.3.1]NON-9-ILO, OCTAHIDRO-INDEN-2-ILO, 2,3-DIHIDRO-1H-FENALEN-1-ILO, ENTRE OTROS; R2 ES =O o H; R3 ES H, ISOINDOLIL-1,3-DIONA, ALCOXILO, ALQUILO, AMINO, BENCILOXILO, -CH2OR5, -CH2N(R5)2; R4 ES H, -CH2OR5; R5 ES H o ALQUILO; EL ANILLO A ES CICLOHEXILO, FENILO OPCIONALMENTE SUSTITUIDO CON ALQUILO, HALOGENO, ALCOXILO. SON COMPUESTOS PREFERIDOS 3,3-BIS-HIDROXIMETIL-7-(CIS-4-ISOPROPIL-CICLOHEXIL)-1-FENIL-1,7-DIAZA-ESPIRO[3.5]NONAN-2-ONA, 7-(CIS-4-ISOPROPIL-CICLOHEXIL)-1-FENIL-1,7-DIAZA-ESPIRO[3,5]NONAN-2-ONA, ENTRE OTROS. TAMBIEN SE REFIERE A UN PROCEDIMIENTO PARA LA PREPARACION. EL COMPUESTO I ES UN AGONISTA/ANTAGONISTA DEL RECEPTOR DE LA ORFANINA OFQ POR LO QUE PUEDE SER UTIL PARA EL TRATAMIENTO DE TRASTORNOS PSIQUIATRICOS, NEUROLOGICOS, FISIOLOGICOS, TRASTORNOS DE ANSIEDAD, ESTRES, DEPRESION, TRAUMAS, EPILEPSIA, CONVULSIONES, CONDICIONES DE DOLOR AGUDO O CRONICO
PE1999000487A 1998-06-12 1999-06-08 Derivados de diaza-espiro[3.5]nonano PE20000548A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP98110804 1998-06-12

Publications (1)

Publication Number Publication Date
PE20000548A1 true PE20000548A1 (es) 2000-07-15

Family

ID=8232114

Family Applications (1)

Application Number Title Priority Date Filing Date
PE1999000487A PE20000548A1 (es) 1998-06-12 1999-06-08 Derivados de diaza-espiro[3.5]nonano

Country Status (28)

Country Link
US (1) US6113527A (es)
EP (1) EP0970957B1 (es)
JP (1) JP3286268B2 (es)
KR (1) KR100344732B1 (es)
CN (1) CN1107066C (es)
AR (1) AR019859A1 (es)
AT (1) ATE204279T1 (es)
AU (1) AU743983B2 (es)
BR (1) BR9902651A (es)
CA (1) CA2274202A1 (es)
DE (1) DE69900220T2 (es)
DK (1) DK0970957T3 (es)
ES (1) ES2162503T3 (es)
HR (1) HRP990188A2 (es)
HU (1) HU220894B1 (es)
ID (1) ID23304A (es)
IL (1) IL130377A0 (es)
MA (1) MA26644A1 (es)
NO (1) NO312590B1 (es)
NZ (1) NZ336189A (es)
PE (1) PE20000548A1 (es)
PL (1) PL333695A1 (es)
PT (1) PT970957E (es)
SG (1) SG79259A1 (es)
SI (1) SI0970957T1 (es)
TR (1) TR199901381A3 (es)
YU (1) YU26499A (es)
ZA (1) ZA993852B (es)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030040479A1 (en) * 2001-07-02 2003-02-27 Omeros Corporation Rotational intrathecal analgesia method and device
EP1406629A1 (en) * 2001-07-02 2004-04-14 Omeros Corporation Method for inducing analgesia comprising administration alternatively of an opioid receptor agonist and an opioid receptor like receptor 1 agonist for and an implantable infusion pump
EP1491212B1 (en) 2002-03-29 2012-08-08 Mitsubishi Tanabe Pharma Corporation Remedy for sleep disturbance
JP2005289816A (ja) 2002-05-14 2005-10-20 Banyu Pharmaceut Co Ltd ベンズイミダゾール誘導体
EP1519939B9 (en) * 2002-07-05 2011-04-06 Targacept, Inc. N-aryl diazaspirocyclic compounds and methods of preparation and use thereof
EP1601674B1 (en) * 2002-09-09 2012-08-08 Janssen Pharmaceutica NV Hydroxyalkyl substituted 1,3,8-triazaspiro[4.5]decan-4-one derivatives useful for the treatment of ORL-1 receptor mediated disorders
GB0323204D0 (en) 2003-10-03 2003-11-05 Novartis Ag Organic compounds
WO2005060947A2 (en) * 2003-12-19 2005-07-07 Sri International Agonist and antagonist ligands of the nociceptin receptor
US20060178390A1 (en) * 2004-08-02 2006-08-10 Alfonzo Jordan 1,3,8-Triazaspiro[4,5]decan-4-one derivatives useful for the treatment of ORL-1 receptor mediated disorders
MX2007002045A (es) * 2004-08-20 2007-03-29 Targacept Inc Uso de compuestos de n-arildiazaespiraciclicos en el tratamiento de adiccion.
US20080247964A1 (en) * 2006-05-08 2008-10-09 Yuelian Xu Substituted azaspiro derivatives
AU2007325355A1 (en) * 2006-11-28 2008-06-05 Janssen Pharmaceutica N.V. Salts of 3-(3-amino-2-(R)-hydroxy-propyl)-1-(4-fluoro-phenyl)-8-(8-methyl-naphthalen-1-ylmethyl) -1,3,8-triaza-spiro[4.5]decan-4-one
CN101679430B (zh) * 2007-04-09 2013-12-25 詹森药业有限公司 用于治疗焦虑和抑郁症的作为orl-1受体的配体的1,3,8-三取代-1,3,8-三氮杂-螺[4.5]癸-4-酮衍生物
KR101704226B1 (ko) 2015-06-30 2017-02-07 현대자동차주식회사 자동차의 쿼터글라스 어셈블리
EP4452416A1 (en) * 2021-12-22 2024-10-30 The Regents Of The University Of California Covalently binding inhibitors of g12s, g12d and/or g12e mutants of k-ras gtpase

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5756743A (en) * 1996-04-10 1998-05-26 Hoechst Marion Roussel Inc. Spiro cyclopent b!indole-piperidines!

Also Published As

Publication number Publication date
DE69900220T2 (de) 2002-05-08
NZ336189A (en) 2000-10-27
ID23304A (id) 2000-04-05
EP0970957A1 (en) 2000-01-12
DK0970957T3 (da) 2001-12-03
SG79259A1 (en) 2001-03-20
YU26499A (sh) 2002-09-19
IL130377A0 (en) 2000-06-01
PT970957E (pt) 2002-02-28
KR20000006060A (ko) 2000-01-25
TR199901381A2 (xx) 2000-01-21
CA2274202A1 (en) 1999-12-12
NO312590B1 (no) 2002-06-03
EP0970957B1 (en) 2001-08-16
BR9902651A (pt) 2000-05-16
AU3498799A (en) 1999-12-23
PL333695A1 (en) 1999-12-20
ATE204279T1 (de) 2001-09-15
JP3286268B2 (ja) 2002-05-27
HU9901911D0 (en) 1999-08-30
HUP9901911A1 (hu) 2000-05-28
DE69900220D1 (de) 2001-09-20
ES2162503T3 (es) 2001-12-16
JP2000053679A (ja) 2000-02-22
AR019859A1 (es) 2002-03-20
NO992873L (no) 1999-12-13
SI0970957T1 (es) 2001-12-31
MA26644A1 (fr) 2004-12-20
ZA993852B (en) 1999-12-13
CN1242366A (zh) 2000-01-26
CN1107066C (zh) 2003-04-30
TR199901381A3 (tr) 2000-01-21
HRP990188A2 (en) 2000-02-29
US6113527A (en) 2000-09-05
KR100344732B1 (ko) 2002-07-19
HU220894B1 (en) 2002-06-29
NO992873D0 (no) 1999-06-11
AU743983B2 (en) 2002-02-14

Similar Documents

Publication Publication Date Title
PE20000548A1 (es) Derivados de diaza-espiro[3.5]nonano
PE59999A1 (es) Derivados de 1,3,8-triaza-espiro[4,5]decan-4-ona-8-sustituidos
PE20030415A1 (es) Derivados policiclicos de guanina como inhibidores de fosfodiesterasa v
PE20000337A1 (es) Pirazolpirimidinas y pirazoltriazinas
PE20020298A1 (es) Derivados de 1,3,8-triaza-espiro[4,5]decan-4-ona como antagonistas de receptores de neuroquinina nk-1
PE46899A1 (es) Derivados de n-fenil-sulfonamida
ES2174836T3 (es) Heterrociclos nitrogenados triciclicos condesados como antagonistas de receptor de la sustancia p.
PH25493A (en) 2,3,4,5-tetrahydro-2-£(imidazol-(or-5)-yl)methyl-ih-pyrido£4,3-b|indol-1-ones , derivatives having 5-ht antagonist activity 3
AU7730298A (en) 5H-thiazolo(3,2-a)pyrimidine derivatives
FI880866A0 (fi) 3-amino-dihydro-(1)-bensopyraner och -bensotiopyraner.
PT93687A (pt) Processo para a preparacao de antagonistas de serotonina de tetra-hidrobenz,d}indole
PE20000540A1 (es) Derivados de diaza-espiro [4.5]decan
PE20010481A1 (es) Derivados de la octahidro-1h-pirido[1,2-a]pirazina 2,7-sustituida como ligandos para receptores de la serotonina
IL75239A (en) Derivatives of 7-(1-(2-aminothiazol-4-yl)-ethen-carboxamido)-4-carboxy-3-cephemmethylaminium inner salt,their preparation,pharmaceutical compositions containing them and their use as growth-promoters in livestock rearing or as antioxidants
EG18586A (en) Cycloalkylamides of(beta,beta)-1-alkyl-6-(substituted)ergolines
PE20000549A1 (es) Espiro[piperidin-4,1`-pirrolo[3.4-c]pirrol]
PE44199A1 (es) Benzo[e]isoindoles y benzo[h]isoquinolinas triciclicos
ATE269329T1 (de) Neue basische derivate von benz(e)isoindol-1-onen und pyrrolo(3,4-c)chinolin-1-onen mit 5-ht3- antagonistischer aktivität, ihre herstellung und ihre therapeutische verwendung
PE86698A1 (es) Derivados de indolina
EP0588500A3 (en) 3-oxadiazolyl-1,6-naphthyridine derivatives with affinity for benzodiazepine receptors
ES525691A0 (es) Procedimiento para la obtencion de derivados de benzoxazina sustituidos
FI963122A0 (fi) Karbamoyylimetyyliureajohdannaiset
UY23448A1 (es) Ciertas cicloalquil y azacicloalquil pirrolopirimidinas: una nueva clase de ligandos de receptores cerebrales del gaba

Legal Events

Date Code Title Description
FG Grant, registration
FD Application declared void or lapsed